<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In myeloid and <z:hpo ids='HP_0005526'>lymphoid leukemias</z:hpo> recurrent chromosomal aberrations can be detected in chromosome region 12p13 </plain></SENT>
<SENT sid="1" pm="."><plain>We characterized the genes involved in t(12;22) (p13;q11) in two patients with myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo> and one with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>MN1, a gene on chromosome 22q11 was shown to be fused to <z:chebi fb="18" ids="30182">TEL</z:chebi>, a member of the family of ETS transcription factors on chromosome 12p13 </plain></SENT>
<SENT sid="3" pm="."><plain>The translocation results in transcription of the reciprocal fusion <z:chebi fb="2" ids="33699">mRNAs</z:chebi>, MN1-<z:chebi fb="18" ids="30182">TEL</z:chebi> and <z:chebi fb="18" ids="30182">TEL</z:chebi>-MN1, of which MN1-<z:chebi fb="18" ids="30182">TEL</z:chebi> is likely to encode an aberrant transcription factor containing the ETS DNA-binding domain of <z:chebi fb="18" ids="30182">TEL</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>In addition to fusion of <z:chebi fb="18" ids="30182">TEL</z:chebi> to the PDGF beta receptor in t(5;12) in <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e>), our data suggest that the involvement of this protein in myeloid <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">leukemogenesis</z:e> could be dual; its isolated protein-protein dimerization and DNA-binding domains may be crucial for the oncogenic activation of functionally different fusion proteins </plain></SENT>
</text></document>